• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子表观遗传学靶点治疗肝脏疾病:当前的挑战与未来展望。

Molecular epigenetic targets for liver diseases: current challenges and future prospects.

机构信息

Centre for Biotechnology and Biomedicine, Department of Cell Techniques and Applied Stem Cell Biology, Medical Faculty of University of Leipzig, Deutscher Platz 5, D-04103 Leipzig, Germany.

Centre for Biotechnology and Biomedicine, Department of Cell Techniques and Applied Stem Cell Biology, Medical Faculty of University of Leipzig, Deutscher Platz 5, D-04103 Leipzig, Germany; Department of Plastic and Hand Surgery, University Hospital Rechts der Isar, Munich Technical University, Munich, Germany.

出版信息

Drug Discov Today. 2017 Nov;22(11):1620-1636. doi: 10.1016/j.drudis.2017.07.008. Epub 2017 Jul 25.

DOI:10.1016/j.drudis.2017.07.008
PMID:28754290
Abstract

Advanced chemotherapy fails to treat liver cancer but recent progress in understanding epigenetic modifications have witnessed promising clinical outcomes. Epigenetic alteration is the alteration of epigenomes (surrounding histone proteins) without changing the DNA sequence. Such epigenetic mechanisms include histone modifications such as methylation, acetylation, phosphorylation and sumoylation followed by changes in the genomic architecture. Current studies involving the understanding of small RNA molecules such as noncoding RNA and microRNA in modulating the chromatin architecture are explained in depth here, along with effects of some novel compounds from recent preclinical and clinical evidence. This review also discusses the current state-of-the-art strategies and the possible scope of investigation to improve the existing treatment methods for liver-related disorders.

摘要

高级化疗未能治疗肝癌,但近年来对表观遗传修饰的理解取得了进展,见证了有前景的临床结果。表观遗传改变是指在不改变 DNA 序列的情况下改变表观基因组(围绕组蛋白的)。这种表观遗传机制包括组蛋白修饰,如甲基化、乙酰化、磷酸化和 sumoylation,随后基因组结构发生变化。目前的研究涉及对小 RNA 分子(如非编码 RNA 和 microRNA)在调节染色质结构中的作用的深入了解,以及来自最近的临床前和临床证据的一些新型化合物的影响。这篇综述还讨论了目前的最新策略和可能的研究范围,以改善与肝脏相关疾病的现有治疗方法。

相似文献

1
Molecular epigenetic targets for liver diseases: current challenges and future prospects.分子表观遗传学靶点治疗肝脏疾病:当前的挑战与未来展望。
Drug Discov Today. 2017 Nov;22(11):1620-1636. doi: 10.1016/j.drudis.2017.07.008. Epub 2017 Jul 25.
2
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease.代谢相关脂肪性肝病的表观遗传药物发现全景。
Trends Genet. 2020 Jun;36(6):429-441. doi: 10.1016/j.tig.2020.03.003. Epub 2020 Mar 28.
3
Epigenetic mechanisms in coronary artery disease: The current state and prospects.冠状动脉疾病中的表观遗传机制:现状与展望。
Trends Cardiovasc Med. 2018 Jul;28(5):311-319. doi: 10.1016/j.tcm.2017.12.012. Epub 2017 Dec 30.
4
Chromatin proteomics and epigenetic regulatory circuits.染色质蛋白质组学与表观遗传调控回路
Expert Rev Proteomics. 2008 Feb;5(1):105-19. doi: 10.1586/14789450.5.1.105.
5
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.心脏肥大和衰竭中的表观遗传修饰和非编码 RNA。
Nat Rev Cardiol. 2015 Aug;12(8):488-97. doi: 10.1038/nrcardio.2015.71. Epub 2015 May 12.
6
Epigenomes as therapeutic targets.表观基因组作为治疗靶点。
Pharmacol Ther. 2015 Jul;151:72-86. doi: 10.1016/j.pharmthera.2015.03.003. Epub 2015 Mar 20.
7
Current advances in epigenetic modification and alteration during mammalian ovarian folliculogenesis.哺乳动物卵巢卵泡发生过程中表观遗传修饰和改变的最新进展。
J Genet Genomics. 2012 Mar 20;39(3):111-23. doi: 10.1016/j.jgg.2012.02.004. Epub 2012 Feb 21.
8
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?索拉非尼之后的肝细胞癌治疗:表观遗传学、微小RNA与微环境。隧道尽头会有曙光吗?
Expert Opin Ther Targets. 2015;19(12):1623-35. doi: 10.1517/14728222.2015.1071354. Epub 2015 Jul 27.
9
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.表观遗传修饰与头颈癌:对肿瘤进展及治疗耐药性的影响
Int J Mol Sci. 2017 Jul 12;18(7):1506. doi: 10.3390/ijms18071506.
10
Epigenetic opportunities and challenges in cancer.癌症中的表观遗传机会与挑战。
Drug Discov Today. 2010 Jan;15(1-2):65-70. doi: 10.1016/j.drudis.2009.10.010. Epub 2009 Nov 6.

引用本文的文献

1
The role of CSTF2 in cancer: from technology to clinical application.CSTF2 在癌症中的作用:从技术到临床应用。
Cell Cycle. 2023 Dec-Dec;22(23-24):2622-2636. doi: 10.1080/15384101.2023.2299624. Epub 2024 Jan 2.
2
Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease.慢性肝病中组蛋白修饰的机制与治疗机遇
Front Pharmacol. 2021 Nov 23;12:784591. doi: 10.3389/fphar.2021.784591. eCollection 2021.
3
lncRNA AK054386 Functions as a ceRNA to Sequester miR-199 and Induce Sustained Endoplasmic Reticulum Stress in Hepatic Reperfusion Injury.
lncRNA AK054386 通过海绵吸附 miR-199 诱导持续内质网应激在肝脏再灌注损伤中的作用
Oxid Med Cell Longev. 2019 Nov 13;2019:8189079. doi: 10.1155/2019/8189079. eCollection 2019.
4
Cell‑specific histone modifications in atherosclerosis (Review).动脉粥样硬化中的细胞特异性组蛋白修饰(综述)。
Mol Med Rep. 2018 Aug;18(2):1215-1224. doi: 10.3892/mmr.2018.9142. Epub 2018 Jun 6.